TY - JOUR
T1 - Enhancement of sphingosine kinase 1 catalytic activity by deletion of 21 amino acids from the COOH-terminus
AU - Hengst, Jeremy A.
AU - Guilford, Jacquelyn M.
AU - Conroy, Elizabeth J.
AU - Wang, Xujun
AU - Yun, Jong K.
PY - 2010/2/1
Y1 - 2010/2/1
N2 - Sphingosine kinase 1 (SphK1) responds to a variety of growth factor signals by increasing catalytic activity as it translocates to the plasma membrane (PM). Several studies have identified amino acids residues involved in translocation yet how SphK1 increases its catalytic activity remains to be elucidated. Herein, we report that deletion of 21 amino acids from the COOH-terminus of SphK1 (1-363) results in increased catalytic activity relative to wild-type SphK1 (1-384) which is independent of the phosphorylation state of Serine 225 and PMA stimulation. Importantly, HEK293 cells stably expressing the 1-363 protein exhibit enhanced cell growth under serum-deprived cell culture conditions. Together the evidence indicates that the COOH-terminal region of SphK1 encompasses a structural element that is necessary for the increase in catalytic activity in response to PMA treatment and that its deletion renders SphK1 constitutively active with respect to PMA treatment.
AB - Sphingosine kinase 1 (SphK1) responds to a variety of growth factor signals by increasing catalytic activity as it translocates to the plasma membrane (PM). Several studies have identified amino acids residues involved in translocation yet how SphK1 increases its catalytic activity remains to be elucidated. Herein, we report that deletion of 21 amino acids from the COOH-terminus of SphK1 (1-363) results in increased catalytic activity relative to wild-type SphK1 (1-384) which is independent of the phosphorylation state of Serine 225 and PMA stimulation. Importantly, HEK293 cells stably expressing the 1-363 protein exhibit enhanced cell growth under serum-deprived cell culture conditions. Together the evidence indicates that the COOH-terminal region of SphK1 encompasses a structural element that is necessary for the increase in catalytic activity in response to PMA treatment and that its deletion renders SphK1 constitutively active with respect to PMA treatment.
UR - http://www.scopus.com/inward/record.url?scp=74149094144&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74149094144&partnerID=8YFLogxK
U2 - 10.1016/j.abb.2009.11.006
DO - 10.1016/j.abb.2009.11.006
M3 - Article
C2 - 19914200
AN - SCOPUS:74149094144
SN - 0003-9861
VL - 494
SP - 23
EP - 31
JO - Archives of Biochemistry and Biophysics
JF - Archives of Biochemistry and Biophysics
IS - 1
ER -